{"id":"basal-plus","_chembl":{"chemblId":"CHEMBL538867","moleculeType":"Small molecule","molecularWeight":"504.78"},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Basal Plus","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T04:28:28.114420+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T04:28:33.392624+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Basal Plus","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T04:28:33.698184+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Smoothened homolog antagonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T04:28:35.266726+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL538867/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T04:28:34.913373+00:00"}},"_dailymed":null,"_scrapedAt":"2026-03-27T23:42:56.993Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T04:28:36.472339+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT07170033","phase":"NA","title":"The Effect of the DASH Diet on Treatment Outcomes in Adults Diagnosed With Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Istanbul Health and Technology University","startDate":"2024-05-06","conditions":"Rheumatoid Arthritis","enrollment":49},{"nctId":"NCT05353049","phase":"NA","title":"How to Bathe a Person With Dementia? A Bathing Intervention Based on Basale Stimulation® for People With Moderate to Severe Dementia","status":"COMPLETED","sponsor":"University of Salamanca","startDate":"2021-11-01","conditions":"Patient Engagement, Behavioral Symptoms","enrollment":50},{"nctId":"NCT04127994","phase":"NA","title":"Glycemic Variability Comparing Two vs Five Meals in Type 2 Diabetes","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2018-08-17","conditions":"Diabetes Mellitus Type 2, Overweight and Obesity, Meal Time","enrollment":50},{"nctId":"NCT05724875","phase":"NA","title":"FLASH Radiotherapy for Skin Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2023-06-22","conditions":"Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma","enrollment":60},{"nctId":"NCT05307185","phase":"NA","title":"Tritordeum-based Foods for IBS Symptoms","status":"COMPLETED","sponsor":"Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis","startDate":"2022-01-17","conditions":"Irritable Bowel Syndrome","enrollment":135},{"nctId":"NCT05929664","phase":"PHASE2","title":"Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2023-07-05","conditions":"Locally Advanced Basal Cell Carcinoma, Basal Cell Carcinoma","enrollment":70},{"nctId":"NCT04128995","phase":"PHASE4","title":"Surgical or Medical Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2019-12-15","conditions":"Diabetes Mellitus, Type 2, Pediatric Obesity, Bariatric Surgery Candidate","enrollment":88},{"nctId":"NCT04744935","phase":"NA","title":"Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Christopher Zachary","startDate":"2021-01-13","conditions":"Basal Cell Carcinoma, Superficial Basal Cell Carcinoma, Nodular Basal Cell Carcinoma","enrollment":40},{"nctId":"NCT07462663","phase":"","title":"SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer","status":"NOT_YET_RECRUITING","sponsor":"Hospital Universitari de Bellvitge","startDate":"2026-05","conditions":"Endometrial Cancer, Endometrial Cancer Stage I, Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I","enrollment":82},{"nctId":"NCT07224321","phase":"PHASE2","title":"INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes","status":"RECRUITING","sponsor":"Mannkind Corporation","startDate":"2026-02","conditions":"Type 1 Diabetes Mellitus","enrollment":100},{"nctId":"NCT07355868","phase":"EARLY_PHASE1","title":"Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy","status":"RECRUITING","sponsor":"Regend Therapeutics","startDate":"2026-03-19","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":12},{"nctId":"NCT03521830","phase":"PHASE2","title":"Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2018-11-27","conditions":"Basal Cell Carcinoma","enrollment":57},{"nctId":"NCT07482956","phase":"NA","title":"BCC-One-Stop-Study","status":"NOT_YET_RECRUITING","sponsor":"University Hospital Augsburg","startDate":"2026-04-01","conditions":"Basal Cell Carcinoma","enrollment":290},{"nctId":"NCT04066504","phase":"","title":"Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries Limited","startDate":"2019-03-11","conditions":"Basal Cell Carcinoma","enrollment":323},{"nctId":"NCT06135506","phase":"NA","title":"Artificial Intelligence/Computer Guided Ridge Splitting for Treating Horizontal Ridge Defects","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2023-12-15","conditions":"Alveolar Bone Resorption, Dental Implant Failure Nos","enrollment":22},{"nctId":"NCT06221397","phase":"","title":"AI-based Medical Device Validation for Early Melanoma Detection","status":"COMPLETED","sponsor":"AI Labs Group S.L","startDate":"2020-09-17","conditions":"Melanoma, Melanoma, Skin","enrollment":105},{"nctId":"NCT06762314","phase":"PHASE2","title":"Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2025-01-20","conditions":"Diabetes","enrollment":105},{"nctId":"NCT02445391","phase":"PHASE3","title":"Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2015-10-20","conditions":"Estrogen Receptor Negative, HER2/Neu Negative, Invasive Breast Carcinoma","enrollment":415},{"nctId":"NCT06945406","phase":"PHASE1","title":"A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2025-05-16","conditions":"Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":124},{"nctId":"NCT04596631","phase":"PHASE3","title":"A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2020-11-02","conditions":"Diabetes Mellitus, Type 2","enrollment":132},{"nctId":"NCT06848530","phase":"NA","title":"Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2025-12-10","conditions":"Movement Disorders","enrollment":100},{"nctId":"NCT06981325","phase":"PHASE2","title":"Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients","status":"RECRUITING","sponsor":"Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest","startDate":"2025-08-07","conditions":"Basal Cell Carcinoma (BCC), First Line Treatment","enrollment":34},{"nctId":"NCT07227350","phase":"PHASE2","title":"L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)","status":"NOT_YET_RECRUITING","sponsor":"Philogen S.p.A.","startDate":"2026-02","conditions":"Locally Advanced Basal Cell Carcinoma","enrollment":180},{"nctId":"NCT06826547","phase":"EARLY_PHASE1","title":"Optimization of Basal Insulin During Ramadan Fasting in Type 2 Diabetic Patients: Comparison Between DAR Recommendations and the Carbohydrate Fasting Test & Metabolic and Inflammatory Consequences","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Tunis El Manar","startDate":"2025-02-15","conditions":"Diabetes Mellitus, Type 2 Treated With Insulin, Fasting, Intermittent, Ramadan Fasting","enrollment":100},{"nctId":"NCT07449260","phase":"","title":"Association Between Serum Thyroid-stimulating Hormone (TSH) and Intracytoplasmic Sperm Injection (ICSI) Outcome in Women Undergoing ICSI","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-01-01","conditions":"Infertility, Female","enrollment":180},{"nctId":"NCT07260916","phase":"NA","title":"Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation","status":"NOT_YET_RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2026-05-15","conditions":"Basal Ganglia Intracerebral Hemorrhage","enrollment":300},{"nctId":"NCT07227870","phase":"PHASE2","title":"L19IL2/TNF in Patients With Basal Cell Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Philogen S.p.A.","startDate":"2026-02","conditions":"Locally Advanced Basal Cell Carcinoma","enrollment":92},{"nctId":"NCT06028126","phase":"NA","title":"Superficial Parasternal Intercostal Plane Block in Cardiac Surgery Trial","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2023-09-08","conditions":"Post-operative Pain, Post-operative Delirium, Post-cardiac Surgery","enrollment":340},{"nctId":"NCT07455331","phase":"PHASE2","title":"Flash Radiotherapy for Skin Cancer","status":"NOT_YET_RECRUITING","sponsor":"Jules Bordet Institute","startDate":"2026-03-23","conditions":"Cutaneous Squamous Cell Carcinoma (CSCC), Basal Cell Carcinoma (BCC)","enrollment":60},{"nctId":"NCT05199584","phase":"PHASE2","title":"A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations","status":"COMPLETED","sponsor":"Endeavor Biomedicines, Inc.","startDate":"2022-05-24","conditions":"Solid Tumors With PTCH1 Loss-of-function Mutations","enrollment":20},{"nctId":"NCT05203302","phase":"NA","title":"Novel Coding Strategies for Children With Cochlear Implants","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2018-07-12","conditions":"Deafness","enrollment":190},{"nctId":"NCT06111508","phase":"NA","title":"The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2023-11-29","conditions":"Type 2 Diabetes","enrollment":30},{"nctId":"NCT06848205","phase":"NA","title":"Percept Transitions in FOG and PD","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2026-02-26","conditions":"Freezing of Gait, Parkinson Disease","enrollment":36},{"nctId":"NCT07215312","phase":"PHASE2","title":"A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2025-10-13","conditions":"Diabetes Mellitus, Type 2","enrollment":100},{"nctId":"NCT07351201","phase":"NA","title":"Effect of Head and Neck Positioning on Lung Sliding in Healthy Volunteers","status":"COMPLETED","sponsor":"Ankara Etlik City Hospital","startDate":"2026-01-20","conditions":"Healthy","enrollment":31},{"nctId":"NCT04416269","phase":"PHASE4","title":"Oral Anti Diabetic Agents in the Hospital","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2020-08-07","conditions":"Diabetes Mellitus","enrollment":255},{"nctId":"NCT07434752","phase":"PHASE4","title":"A Study to See if an Energy Drink With Caffeine and Green Tea Increases Fat Burning When Exercising","status":"NOT_YET_RECRUITING","sponsor":"RDC Clinical Pty Ltd","startDate":"2026-02","conditions":"Exercise","enrollment":40},{"nctId":"NCT06368817","phase":"PHASE2","title":"A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2024-10-22","conditions":"Basal Ganglia Germinoma, Central Nervous System Germinoma, Diabetes Insipidus","enrollment":240},{"nctId":"NCT07422818","phase":"NA","title":"Non-invasive Evaluation of Patients With Angina and Non-obstructive Coronary Artery Disease","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2026-03","conditions":"ANOCA - Angina With Non-obstructive Coronary Arteries","enrollment":35},{"nctId":"NCT07423559","phase":"NA","title":"Relapse Among Diabetic Ketoacidosis Patients Maintained Basal Bolus Insulin Administration in Combination With Continuous Intravenous Insulin Infusion VS Non Maintaining Basal Insulin Patients","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-11-30","conditions":"Diabetic Ketoacidosis, Insulin, Intensive Care Unit Stay","enrollment":100},{"nctId":"NCT07390175","phase":"NA","title":"Ablation of Human Cardiac Fibrillation Based on Models of Hierarchical Organization of Tissue Excitation","status":"RECRUITING","sponsor":"Hospital San Carlos, Madrid","startDate":"2025-01-20","conditions":"Atrial Fibrillation (AF), Ablation Treatment, TerFib_Hyerarchy","enrollment":78},{"nctId":"NCT05785832","phase":"NA","title":"A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes","status":"COMPLETED","sponsor":"Tandem Diabetes Care, Inc.","startDate":"2023-06-01","conditions":"Type 2 Diabetes Treated With Insulin","enrollment":319},{"nctId":"NCT07286318","phase":"EARLY_PHASE1","title":"A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients","status":"NOT_YET_RECRUITING","sponsor":"Marissa Lobl","startDate":"2026-03-01","conditions":"Skin Cancer, Cutaneous Squamous Cell Carcinoma (CSCC), Actinic Keratosis (AK)","enrollment":20},{"nctId":"NCT06778109","phase":"NA","title":"Manage Your Workingnegative Thoughts Through Hypnosis","status":"COMPLETED","sponsor":"University of Padova","startDate":"2025-02-06","conditions":"Stress, Stress Disorders","enrollment":26},{"nctId":"NCT06484374","phase":"NA","title":"A Multicenter, RAndomlzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With Al-assisted Robotic guidanCe for Hemorrhagic Stroke: Large Basal Ganglia Hemorrhage","status":"RECRUITING","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2025-12-20","conditions":"Hematoma Brain, Large Basal Ganglia Hemorrhage","enrollment":198},{"nctId":"NCT06273293","phase":"NA","title":"Postprocedural Contrast Mediated FFR Plus Intracoronary Infusion of Nitroglycerin in Multivessel Patients (PROMETEUS TRIAL)","status":"RECRUITING","sponsor":"Fundación EPIC","startDate":"2024-05-31","conditions":"Coronary Disease","enrollment":150},{"nctId":"NCT06024928","phase":"NA","title":"Automated Insulin Delivery (AID) for Basal Insulin Titration in Type 2 Diabetes","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2024-06-18","conditions":"Type 2 Diabetes","enrollment":23},{"nctId":"NCT07256730","phase":"NA","title":"Computer-Guided Ridge Split and Expansion Using an Electromagnetic Mallet","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-08-27","conditions":"Reconstruction of Horizontal Ridge Defects","enrollment":22},{"nctId":"NCT07144384","phase":"EARLY_PHASE1","title":"Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma","status":"RECRUITING","sponsor":"Kirsten Johnson","startDate":"2025-10-16","conditions":"Skin Basal Cell Carcinoma, Skin Nodular Basal Cell Carcinoma, Skin Squamous Cell Carcinoma","enrollment":40},{"nctId":"NCT05944432","phase":"NA","title":"CGM Use in Adults With Type 2 Diabetes on Basal Insulin","status":"ACTIVE_NOT_RECRUITING","sponsor":"Abbott Diabetes Care","startDate":"2023-07-14","conditions":"Diabetes Mellitus, Type 2","enrollment":470},{"nctId":"NCT07361822","phase":"NA","title":"Comparison of Cumulative Opioid Consumption Between Variable-Rate Feedback Infusion and Fixed-Rate Basal Infusion Modes of Intravenous PCA Following Mixed Surgery","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-12-30","conditions":"Surgery, Pain Management, Opioid Consumption","enrollment":426},{"nctId":"NCT07401641","phase":"NA","title":"Effect of Dezocine Versus Nalbuphine Combined With Sufentanil on Postoperative Analgesia, Complications, and Free Flap Survival in Patients Undergoing Oral Cancer Radical Surgery: A Randomized Controlled Clinical Trial.","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-06-01","conditions":"Oral Cancer, Postoperative Pain Management, Free Tissue Flaps","enrollment":60},{"nctId":"NCT06647459","phase":"","title":"Defining the Risk of Ventricular Tachycardia in Genetic Forms of Early-onset Atrial Fibrillation","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-12-13","conditions":"Ventricular Tachycardia, Atrial Fibrillation","enrollment":200},{"nctId":"NCT07397377","phase":"NA","title":"prTMS as an Intervention for Bradykinesia in Parkinson's Disease","status":"RECRUITING","sponsor":"Danish Research Centre for Magnetic Resonance","startDate":"2025-12-16","conditions":"Bradykinesia, Parkinson Disease","enrollment":27},{"nctId":"NCT02188680","phase":"NA","title":"Irritable Bowel Syndrome and Low FODMAP Diet","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2014-01","conditions":"Irritable Bowel Syndrome","enrollment":112},{"nctId":"NCT05889507","phase":"PHASE3","title":"Cooling in Mild Encephalopathy","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2024-03-15","conditions":"Neonatal Encephalopathy, Newborn Asphyxia","enrollment":426},{"nctId":"NCT06907095","phase":"NA","title":"Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals","status":"NOT_YET_RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2026-02","conditions":"Risk of Breast Cancer, Risk of Gynaecological Cancer, Risk of Colorectal Cancer","enrollment":5909},{"nctId":"NCT06731790","phase":"NA","title":"Role of the Nuclear Pore Component RANBP2 in Inflammatory Responses to Viral Infections","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2025-04-24","conditions":"Rare Genetic Disease, Acute Necrotizing Encephalopathy","enrollment":35},{"nctId":"NCT07231926","phase":"NA","title":"Intrathecal Morphine for Recovery and Outcomes After VATS","status":"RECRUITING","sponsor":"Ataturk University","startDate":"2025-12-01","conditions":"Postoperative Pain Management in Video-Assisted Thoracoscopic Surgery","enrollment":52},{"nctId":"NCT06624475","phase":"PHASE2","title":"Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2025-08-21","conditions":"Basal Cell Carcinoma","enrollment":30},{"nctId":"NCT06776315","phase":"NA","title":"The Effect of Exercise Training on lncRNA Expression in Asthma","status":"COMPLETED","sponsor":"Saglik Bilimleri Universitesi","startDate":"2023-07-13","conditions":"Rehabilitation, Pulmonary Rehabilitation, Long Noncoding RNA","enrollment":84},{"nctId":"NCT07387003","phase":"PHASE2","title":"Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Gan & Lee Pharmaceuticals.","startDate":"2026-03-20","conditions":"Type 2 Diabetes (T2DM)","enrollment":300},{"nctId":"NCT07381972","phase":"PHASE3","title":"Photodynamic Therapy Associated With Sonodynamic Therapy for the Treatment of Nodular Basal Cell Carcinoma","status":"RECRUITING","sponsor":"University of Sao Paulo","startDate":"2025-11-24","conditions":"Nodular Basal Cell Carcinoma of Skin","enrollment":142},{"nctId":"NCT06809543","phase":"NA","title":"Clinical Benefits and Safety of Tropho Tend in the Management of Painful Rotator Cuff Tendinopathy","status":"RECRUITING","sponsor":"Mastelli S.r.l","startDate":"2024-12-10","conditions":"Rotator Cuff Tendinopathy","enrollment":60},{"nctId":"NCT05929235","phase":"PHASE1","title":"A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma","status":"RECRUITING","sponsor":"Flare Therapeutics Inc.","startDate":"2023-08-24","conditions":"Advanced Urothelial Carcinoma, Oral Drug Administration, Open Label","enrollment":120},{"nctId":"NCT07378267","phase":"NA","title":"Effect of Intermittent Fasting and Mediterranean Diet on Body Composition and Nutritional Intake","status":"COMPLETED","sponsor":"Selcuk University","startDate":"2023-02-18","conditions":"Obesity & Overweight","enrollment":100},{"nctId":"NCT06623201","phase":"PHASE1","title":"Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas","status":"RECRUITING","sponsor":"Nathalie Zeitouni","startDate":"2024-10-07","conditions":"Basal Cell Carcinoma (BCC)","enrollment":20},{"nctId":"NCT07375121","phase":"NA","title":"Comparison of the Efficacy and Safety of Fixed-rate Basal Infusion Mode and Time-programmed Decremental Background Infusion Mode of Intravenous PCA Following Mixed Surgery","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-12-30","conditions":"Surgery, Pain Management, Opioid Consumption","enrollment":450},{"nctId":"NCT05651828","phase":"EARLY_PHASE1","title":"Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2023-03-23","conditions":"Advanced Basal Cell Carcinoma","enrollment":34},{"nctId":"NCT04989946","phase":"PHASE1, PHASE2","title":"Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2021-12-16","conditions":"Prostate Cancer","enrollment":60},{"nctId":"NCT07352748","phase":"","title":"Exploiting Heterogeneity in Hormone Therapy Response to Reveal Early Determinants of Drug Resistance in Advanced PCa","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universita di Verona","startDate":"2024-10-17","conditions":"Metastatic Prostate Cancer","enrollment":30},{"nctId":"NCT07371299","phase":"","title":"Correlations Between Subjective and Objective Responses to Cochlear Implant Stimulation","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-01-15","conditions":"Severe to Profound Sensorineural Hearing Loss","enrollment":60},{"nctId":"NCT07370922","phase":"PHASE2","title":"Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-11-22","conditions":"Transfusion Dependent Beta Thalassemia","enrollment":80},{"nctId":"NCT07257094","phase":"","title":"Nasal Reconstruction FACE-Q : French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Rehabilitation Following Nasal Skin Cancer","status":"RECRUITING","sponsor":"Hôpital NOVO","startDate":"2026-01-10","conditions":"Carcinoma","enrollment":346},{"nctId":"NCT06422936","phase":"PHASE2","title":"Clinical Trial to Evaluate BO-112 in Patients With Basal Cell Carcinoma (BCC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Highlight Therapeutics","startDate":"2024-05-27","conditions":"Basal Cell Carcinoma","enrollment":60},{"nctId":"NCT07361666","phase":"","title":"Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positivity in Head and Neck Skin Cancer, and the Relationship Between Preoperative Assessment Methods, Inadequate Excision Margins, and Tumor Recurrence","status":"NOT_YET_RECRUITING","sponsor":"Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji","startDate":"2025-12-23","conditions":"Basal Cell Carcinoma of Skin, Cutaneous Squamous Cell Carcinoma (CSCC), Cutaneous Squamous Cell Carcinoma in Situ (CSCCis)","enrollment":400},{"nctId":"NCT01239550","phase":"NA","title":"Insulin Detemir in Obesity Management","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University","startDate":"2011-04","conditions":"Diabetes, Obesity","enrollment":240},{"nctId":"NCT07359963","phase":"EARLY_PHASE1","title":"Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND007 Cell Therapy","status":"NOT_YET_RECRUITING","sponsor":"Regend Therapeutics","startDate":"2026-02-15","conditions":"Idiopathic Pulmonary Fibrosis (IPF)","enrollment":12},{"nctId":"NCT03889912","phase":"PHASE1","title":"Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2019-04-11","conditions":"Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma","enrollment":97},{"nctId":"NCT06716424","phase":"PHASE4","title":"A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2025-01-06","conditions":"Type 2 Diabetes","enrollment":105},{"nctId":"NCT06334068","phase":"NA","title":"SHOrt-term Glycemic Control for Reducing Post-SURGical Complications","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2024-05-08","conditions":"Diabetes, Uncontrolled Diabtetes","enrollment":53},{"nctId":"NCT06694519","phase":"NA","title":"Radiofrequency and Exercise-based Rehabilitation on Symptoms Associated With Pelvic Floor Dysfunctions in Breast Cancer","status":"RECRUITING","sponsor":"SERGIO MONTERO NAVARRO","startDate":"2025-01-30","conditions":"Breast Cancer, Genitourinary Syndrome, Radiofrequency","enrollment":117},{"nctId":"NCT05909332","phase":"PHASE3","title":"Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)","status":"RECRUITING","sponsor":"Fudan University","startDate":"2023-06-20","conditions":"Breast Cancer, Triple Negative Breast Cancer","enrollment":764},{"nctId":"NCT07350889","phase":"NA","title":"Effects of a Specific Dietary Program on Overweight/Obese Women With Polycystic Ovary Syndrome: A Multicenter, Prospective, Randomized Controlled Clinical Study","status":"NOT_YET_RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-01-15","conditions":"Polycystic Ovary Syndrome (PCOS)","enrollment":160},{"nctId":"NCT06280703","phase":"PHASE1","title":"A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2024-05-15","conditions":"Healthy, Type 1 Diabetes Mellitus","enrollment":118},{"nctId":"NCT05482126","phase":"","title":"Sensory Filtering in the Human Basal Ganglia as a Mechanism of Parkinson's Disease","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2022-06-08","conditions":"Parkinson Disease","enrollment":30},{"nctId":"NCT07348432","phase":"","title":"The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes","status":"RECRUITING","sponsor":"McGill University","startDate":"2024-07-29","conditions":"Insulin Dependent Diabetes Mellitus, Feeding and Eating Disorders, Eating Behavior","enrollment":106},{"nctId":"NCT03573401","phase":"PHASE3","title":"Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Biofrontera Inc.","startDate":"2018-09-25","conditions":"Superficial Basal Cell Carcinoma","enrollment":187},{"nctId":"NCT06871761","phase":"PHASE3","title":"A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2024-05-08","conditions":"Adult Patients With Type 2 Diabetes","enrollment":393},{"nctId":"NCT05724134","phase":"PHASE1","title":"Pancreatic Clamp in NAFLD","status":"COMPLETED","sponsor":"Columbia University","startDate":"2023-08-29","conditions":"Insulin Resistance, Prediabetic State, Hyperinsulinemia","enrollment":18},{"nctId":"NCT07112339","phase":"PHASE4","title":"A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes","status":"RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2025-08-15","conditions":"Diabetes Mellitus, Type 2","enrollment":586},{"nctId":"NCT06465719","phase":"NA","title":"A Trial for Minimally Invasive Neurosurgery With AI-assisted Robotic Guidance for Moderate Basal Ganglia Hemorrhage (RAINBOW-MBH)","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-09-30","conditions":"Basal Ganglia Hemorrhage","enrollment":330},{"nctId":"NCT07205263","phase":"NA","title":"RAINBOW-ICH Trial of AI Guided Minimally Invasive Neurosurgery for ICH","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-09-30","conditions":"Basal Ganglia Hemorrhage, Intraventricular Hemorrhage, Brainstem Stroke","enrollment":1000},{"nctId":"NCT06445946","phase":"PHASE4","title":"DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-08-01","conditions":"Gestational Diabetes Mellitus, Pregnancy, High Risk","enrollment":1572},{"nctId":"NCT05653921","phase":"","title":"Prospective Study to Validate the Imaging Biomarker for NCP (R33)","status":"SUSPENDED","sponsor":"Tufts Medical Center","startDate":"2022-12-16","conditions":"Dry Eye Syndromes, Corneal Disease","enrollment":438},{"nctId":"NCT04616248","phase":"PHASE1","title":"In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Southern California","startDate":"2023-01-09","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8","enrollment":14},{"nctId":"NCT06603012","phase":"NA","title":"Behavioral Intervention for Lifestyle Physical Activity in Parkinson's Disease","status":"NOT_YET_RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2026-01","conditions":"Parkinson Disease (PD)","enrollment":50},{"nctId":"NCT07320846","phase":"NA","title":"The Effect of Exercise Training on lncRNA Expression in Rheumatoid Arthritis","status":"RECRUITING","sponsor":"Saglik Bilimleri Universitesi","startDate":"2024-05-18","conditions":"Exercise, Pulmonary Rehabilitation, Interstitial Lung Disease","enrollment":39},{"nctId":"NCT07311070","phase":"PHASE3","title":"Treatment of Basal Cell Carcinoma (BCC) of the Skin, of the Morpheiform, Infiltrative, and Noduloulcerative Types in Inoperable Patients and Not Suitable for Radiotherapy Using Formulated Methylene Blue","status":"ENROLLING_BY_INVITATION","sponsor":"Daryoush Hamidi Alamdari, PhD","startDate":"2025-10-21","conditions":"Advanced Basal Cell Carcinoma (BCC), Inoperable Disease, Morpheaform Basal Cell Carcinoma","enrollment":20},{"nctId":"NCT07208591","phase":"PHASE3","title":"To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome","status":"RECRUITING","sponsor":"Staidson (Beijing) Biopharmaceuticals Co., Ltd","startDate":"2025-10-31","conditions":"Acute Respiratory Distress Syndrome (ARDS)","enrollment":406}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"HYPOGLYCAEMIA"},{"count":1,"reaction":"HYPOTHYROIDISM"}],"crossReferences":{"chemblId":"CHEMBL538867"},"_approvalHistory":[],"publicationCount":158,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Lantus (insulin glargine)","Apidra (insulin glulisine)"],"phase":"marketed","status":"active","brandName":"Basal Plus","genericName":"Basal Plus","companyName":"Guillermo Umpierrez, MD","companyId":"guillermo-umpierrez-md","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":3,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T04:28:36.472339+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}